ESR1 and breast carcinoma: Since estrogen exerts its effects by binding to estrogen receptors, when fulvestrant competitively binds to estrogen receptors, estrogen has no chance to attach to breast cells and regulate their growth and reproduction, thereby achieving the goal of treating breast cancer.